|
|
Correlation Between Serum HB-EGF and GDF15 Levels and Prognosis of Ovarian Cancer Patients undergoing Surgical Treatment |
Gao limei |
Henan Zhecheng Hospital of Traditional Chinese Medicine,Zhecheng 476200,Henan |
|
|
Abstract Objective To investigate the correlation between serum levels of heparin-binding epidermal growth factor(HB-EGF)and growth differentiation factor 15(GDF15)and the prognosis of patients with ovarian cancer undergoing surgical treatment.Methods A prospective randomized trial method was used to select 90 patients with ovarian cancer who received surgical treatment as the research objects.All the selected patients received serum HB-EGF and GDF15 levels before surgery,followed up for 3 years,observed the prognosis of patients,and analyzed the correlation between serum HB-EGF and GDF15 levels and the prognosis of patients with ovarian cancer surgically treated.Results Among the 90 ovarian cancer patients,14 had poor prognosis,accounting for 15.56%;76 had good prognosis,accounting for 84.44%;the serum HB-EGF and GDF15 levels in the poor prognosis group were higher than those in the good prognosis group,and the difference was statistically significant(P<0.05).general bivariate Pearson correlation analysis found that serum HB-EGF and GDF15 levels were positively correlated with the occurrence of poor prognosis(r>0,P<0.05);ROC curve was drawn,the results showed that serum HB-EGF and GDF15 levels predicted The AUCs of poor prognosis were all>0.8,which had a certain predictive value.Conclusion The levels of serum HB-EGF and GDF15 in patients with ovarian cancer are closely related to the prognosis after surgical treatment.In the future,the detection of serum HB-EGF and GDF15 levels can be used to evaluate the prognosis of patients with ovarian cancer and provide a reference for early prevention and treatment.
|
Received: 09 July 2022
|
|
|
|
|
[1] 赵慧慧,杜泽清,渠冉,等.卵巢癌免疫治疗的研究进展[J].河北医药,2019,41(2):273-277. [2] 王海妮,陈安青.血清IFN-γ,IL-2,EGF预测鼻咽癌患者放疗敏感性和预后的相关性分析[J].临床输血与检验,2020,22(3):300-304. [3] 吴烁,金凤岚,肖健存.生长分化因子15和胃癌抗原724在胃癌患者血清中的变化及临床意义[J].中国现代医学杂志,2019,29(23):30-33. [4] 谢幸,苟文丽.《妇产科学》[M].8版,北京:人民卫生出版社,2014:321-326. [5] 李婉,孙丽美,刘禹池,等.激素受体与卵巢癌预后、发病机制及治疗的研究进展[J].现代肿瘤医学,2017,25(4):657-660. [6] 曾文,蒙臣,王雪,等.肝素结合样表皮生长因子在机体各组织器官损伤中的修复作用研究进展[J].山东医药,2020,60(30):100-104. [7] 张莉娟,何彬彬,黄月红,等.HB-EGF对HSC-T6细胞Ras/ERK通路的激活及对MMP-2、TIMP-1表达的影响[J].福建医科大学学报,2016,50(2):69-73. [8] 徐雁飞,聂敦利,曾敏.卵巢癌患者血清HB-EGF水平及与临床病理参数和预后的关系[J].中国妇幼保健,2020,35(10):1911-1914. |
[1] |
Ma Yan, Ding Yong, Wang Chenmeng. Effect of CRRT on Nutrition and Micro Inflammation in Patients with Severe Infection[J]. journal1, 2023, 43(4): 18-20. |
[2] |
. [J]. journal1, 2023, 43(4): 50-52. |
[3] |
. [J]. journal1, 2023, 43(3): 61-62. |
[4] |
. [J]. journal1, 2023, 43(3): 80-82. |
[5] |
. [J]. journal1, 2023, 43(3): 142-144. |
[6] |
. [J]. journal1, 2023, 43(2): 50-52. |
|
|
|
|